The Marque The Marque
The Marque
About The Marque Profiles Contact

Stephen DeCherney, MD, MPH

Chief Medical Officer

KNOW Bio

Chapel Hill, NC, USA

Stephen DeCherney, MD, MPH
Bryson DeChambeau
James Deen
Discovery Land Company

Stephen DeCherney, MD, MPH’s Biography

Stephen DeCherney, MD, MPH, is Professor of Medicine and former Professor (Adjunct) of Business in the Kenan-Flagler School of Business, at University of North Carolina. Stephen is board certified in Internal Medicine and Endocrinology, Diabetes, and Metabolism and was named as one of the Best Doctors in America.

Earlier in his career, Stephen was the CEO of Health Decisions, Inc. and now serves on their Board of Directors. Health Decisions is a full-service CRO specializing in clinical studies of therapeutics for women’s health. He also served as President, Global CRO at Quintiles Transnational Corporation and was an Independent Director of Theorem Clinical Research Company.

Currently, Stephen serves on the Board of KNOW Bio, a subsidiary of Novan that develops and produces nitric oxide-based therapies, and the Board of Directors of Robert F. Kennedy Human Rights. He also serves as a Trustee of the University of Delaware Research Foundation and the Christiana Care Health System, and is a US Representative for the William Harvey Research Foundation, Queen Mary University, London. Previously, Stephen was a Board Member of Symyx Corporation, also serving on their Audit Committee. He was a senior advisor to the London Genetics Company, Member of the Farmer Food Share Board of Trustees and Chairman of their Finance Subcommittee.

Stephen graduated with a BA in Biology from Columbia College of Columbia University, New York, where he was awarded the Columbia College Alumni Achievement Award granted to the “Senior Adjudged Most Outstanding in Qualities of Mind, Character, and Service to the College”. He earned his MD from the Lewis Katz School of Medicine at Temple University, Philadelphia and his MPH, Healthcare Policy and Management, from Columbia University School of Public Health.

Stephen DeCherney, MD, MPH’s Newsfeed

EIN Presswire
Industry Leaders Join e4 Board of Advisors

 e4 is pleased to announce that Stephen DeCherney, MD, MPH, Adrienne Kirby, PhD, FACHE, and Parris Boyd have joined e4's newly created Board of Advisors. “We are thrilled to have these esteemed individuals join e4’s Board of Advisors,” said Niall Doherty, President and Co-Founder, e4. “e4 has grown consistently over the past 15 years...The e4 Board of Advisors will be instrumental in providing strategic guidance as we continue to put our clients first and position e4 for the future.”

Stephen DeCherney, MD, MPH’s Background

KNOW Bio
Chief Medical Officer
Sep 2019 - Present
Durham, NC, USA
KNOW Bio, based in the Research Triangle Park area of North Carolina, is a nitric oxide life science incubator for operating companies utilizing leveraged drug development models using small teams with high quality service contractors and suppliers.
University of North Carolina School of Medicine
Professor of Medicine | Division of Endocrinology
2009 - Present
Chapel Hill, NC, USA
The Division of Endocrinology at UNC has a long tradition of excellence in basic science, and translational and clinical research. Faculty research focuses on new modalities for treatment of diabetes and obesity, the factors that are responsible for improving bone mineral density, molecular mechanisms of obesity, and lipid metabolism, particularly as it relates to insulin secretion.
View allHide

Current Board Positions

e4 Services
Board of Advisors
Nov 2020 - Present
Philadelphia, PA, USA
e4 is a leading national healthcare consulting and professional services company and provider of IT, Revenue Cycle, Clinical Optimization, HIM, CDI, and Coding solutions. e4 also specializes in complex program and change management, utlizing LEAN and proprietary engineered software to maximize outcomes and efficiencies.
Pharm-Olam
Board of Directors
Jun 2020 - Present
Houston, TX, USA
Founded in 1994, Pharm-Olam is an award-winning CRO. It specialize in life-threatening therapeutic areas such as oncology, hematology, infectious disease, rare disease, allergy, and autoimmune. Since its early days, Pharm-Olam has garnered a reputation for taking on and successfully executing the most challenging local and global clinical trials.
View allHide

Previous Board Positions

Farmer Foodshare
Board of Trustees & Finance Subcommittee
Durham, NC, USA
Farmer Foodshare was established with the aim of making fresh, local food available to everyone in the community and to make sure that the farmers producing the food make a healthy living.
Theorem Clinical Research Company (Chiltern)
Independent Director
London, UK
Chiltern, a leading global contract research organization acquired Theorem Clinical Research, strengthening its position as the largest mid-sized provider of comprehensive, clinical development services.
View allHide

Current Advisory Roles

Anagenesis Capital Partners
Executive Advisor
Jan 2017 - Present
New York, NY, USA
Anagenesis Capital Partners is an investment firm focused on making investments in leading middle market healthcare and consumer companies across North America.

Previous Advisory Roles

London Genetics Limited
Senior Advisor
London, UK
London Genetics Limited is a commercial company created to facilitate and manage partnerships between the healthcare industry and London centres of excellence in genetics and genomics-based medical research.

Philanthropy

RFK / Robert F. Kennedy Human Rights
Board of Trustees
Dec 2016 - Present
New York, NY, USA
Robert F. Kennedy Human Rights, founded in 1968, is led by human rights activist and lawyer Kerry Kennedy and advocates for a more just and peaceful world. Working alongside local activists to ensure lasting positive change in governments and corporations, the RFK team includes leading attorneys, advocates, entrepreneurs and writers united by a commitment to social justice.
Christiana Care Health System
Fmr. Trustee
Wilmington, DE, USA
Christiana Care Health System is a not-for-profit health system that believes that the key to providing truly great health care is to partner with patients and their families, building a system of care that is effective, affordable and valuable to everyone.
View allHide

Publications

The impact of post‐transplant diabetes mellitus on liver transplant outcomes
Co-author
Mar 2019
Post‐transplant diabetes mellitus (PTDM) is common after liver transplantation (LT). Yet, how PTDM relates to graft outcomes and survival needs elucidation as more individuals are transplanted for nonalcoholic fatty liver disease (NAFLD). Post‐transplant diabetes mellitus occurs rapidly in the post‐LT period and is a significant problem for both NAFLD and non‐NAFLD LT recipients.

Stephen DeCherney, MD, MPH’s Education

Columbia University
MPH, Healthcare Policy & Management
1996 - 1998
View allHide